Evidence map›Paper›PMID 34412709›Full record

SynthesisEuropean journal of medical research2021

The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.

Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Mohammad Mehrtak, Amirali Karimi, Tayebeh Noori, Pegah Mirzapour, Alireza Shojaei, Mehrzad MohsseniPour, Seyed Peyman Mirghaderi, Sanam Alilou and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in European journal of medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Hyperoxia: Effective Mechanism of Hyperbaric Treatment at Mild-Pressure.International journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Can Hyperbaric Oxygen Therapy Be Used to Treat Children after COVID-19? A Bibliographic Review.International journal of environmental research and public health · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Shahram OliaeiHBOT Research Center, Golestan Hospital, Islamic Republic of Iran, Navy and AJA Medical University, Tehran, Iran.
SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad MehrtakHealthcare Services Management, School of Medicine and Allied Medical Sciences, Ardabil University of Medical Sciences, Ardabil, Iran.
Amirali KarimiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Tayebeh NooriDepartment of Health Information Technology, Zabol University of Medical Sciences, Zabol, Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Alireza ShojaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mehrzad MohsseniPourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Peyman MirghaderiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sanam AlilouSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parnian ShobeiriSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hadiseh Azadi CheshmekabodiHealth Information Technology, School of Health Information Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Esmaeil MehraeenAMAD Research Institute, Supreme National Defense University, Tehran, Iran. es.mehraeen@gmail.com.ORCID http://orcid.org/0000-0003-4108-2973
Omid DadrasDepartment of Global Health and Socioepidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Iranian Institute for Health Sciences Research · IRTehran University of Medical Sciences · IRIran University of Medical Sciences · IRArdabil University of Medical Sciences · IRGolestan University · IRKyoto University · JPZabol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOxygenation serves as a cornerstone in the treatment of COVID-19, and several methods have been extensively studied so far. Herein, we aimed to systematically review the studies discussing hyperbaric oxygen therapy (HBOT) to examine its reported efficacy and adverse events in patients with COVID-19.

methodsWe systematically searched and retrieved the relevant articles using keywords on the online databases, including PubMed, Scopus, Embase, Web of Science, and Cochrane databases up to April 11th, 2021. The retrieved records underwent a two-step title/abstract and full-text screening process, and the eligible papers were identified. National Institutes of health (NIH) quality assessment tool was used for this study. This study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) with ID CRD42021269821.

resultsEight articles from three countries were included. All the included studies had good and fair quality scores, with no poor studies included in this systematic review (Good: n = 5, Fair: n = 3). Studies were divided into clinical trials and case reports/series. Most of the studies used HBOT less than 1.5-2 absolute atmospheres (ATA) for 90 min sessions and thereafter sessions were decreased to 60 min. Trials demonstrated most of the patients recovered after receiving HBOT, and blood oxygen saturation increased after several sessions of HBOT.

conclusionOverall, HBOT seems to be a safe and effective oxygenation method in patients with COVID-19. However, there is limited knowledge and evidence regarding the effects and mechanism of HBOT in COVID-19 treatment, and further evaluations require extensive well-designed studies.

Indexed as

Clinical Trials as TopicCOVID-19COVID-19 Drug TreatmentHumansHyperbaric OxygenationHypoxiaOxygenSARS-CoV-2Treatment OutcomeUnited StatesOxygenCOVID-19Hyperbaric oxygenationHyperbaric oxygen therapySARS-CoV-2

Identifiers

PMID34412709
PMCPMC8374420
OpenAlexW3193495739

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.